Steven Perrin - 23 Nov 2022 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
President, Director
Signature
/s/ Steve Perrin
Issuer symbol
ELDN
Transactions as of
23 Nov 2022
Net transactions value
+$2,597
Form type
4
Filing time
23 Nov 2022, 15:05:35 UTC
Previous filing
02 Feb 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELDN Common Stock Purchase $2,597 +1,000 $2.60 1,000 23 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 reports an open market purchase by the Reporting Person of shares of common stock in accordance with the Issuer's trading policies.